PTPN22 and Autoimmunity: A reasonable hypothesis is that the genetic risk for autoimmunity is greater in individuals and families with multiple diagnoses of AIDs, and that for example the SNPs strongly associated with multiple AIDs (such as IL2RA or PTPN22 [11, 18]) would be associated with clustering of these diseases.